‼️ There are many unanswered questions, unmet needs & work to be done👇
A global expert consensus meeting 🌍 is being planned to help address these needs
✋Please get in touch if you work or research in this space & would like to be involved
4/4
@CMRI_AUS@COBLH@PeterMacCC
Prof Thomas is recognised for his leadership in the development of precision oncology in Australia, which has extended the lives of thousands of incurable cancer patients through the use of genomics. #cancerNSWawards@GarvanInstitute
Professor David Thomas is the 2024 Outstanding Cancer Researcher of the Year, recognised for a career driving breakthroughs and innovation not just in NSW, but globally. Congratulations, Prof Thomas! #cancerNSWawards@GarvanInstitute
A proud moment for @OmicoAustralia - Prof David Thomas, receiving NSW’s highest cancer accolade @ the Premier’s Awards, recognising his remarkable work in sarcoma research, genomics & precision oncology. Our sincere thanks for all you do for those living with sarcoma.
This is massive news. Huge thanks to @JaneMTiller and the team, but particularly the families who shared their stories countless times to give the lived experience.
👏👏👏👏👏
Marking #RareCancers Awareness Day - Omico’s Professor David Thomas' Address will address the National Press Club Wednesday, 26 June at 12:30pm (AEST)! You can watch the broadcast live on the ABC TV Network. Info: https://t.co/3qA3STyRHd @RareCancers#PrecisionOncology #CancerMeetsItsMatch
We are thrilled share that over 5000 patients have been referred to PrOSPeCT*, by over 750 clinicians! For more information on Omico and PRoSPeCT, click here https://t.co/rA7D4JQXRT #CancerMeetsItsMatch#PrecisionOncology#ClinicalTrials
Patient organisations took a consensus statement to @MarkButler last week calling for life-saving cancer drugs to be made urgently available to thousands more Aussies. Read it here: https://t.co/Ae5Aa2H0yA
We are excited to have APOS 24 featured on #MedNews. 'Professor David Thomas wants to solve a problem. Australian cancer patients are waiting years to get access to new medicines through the PBS after they are approved by the TGA... Read more: https://t.co/cYRG0mJaAH
Today, on #WorldCancerDay, we acknowledge people who have a cancer diagnosis & their families, & the challenges that come with this. Our appreciation also goes to every patient advocate, researcher & health care professional who are helping improve treatment & care.
Liddy shriver award presentation by 🇦🇺 @ballingermandy at #CTOS2023
Incredible work & presentation 🤩 👏
#ISKS -> Genetic predisposition in
#sarcoma -> #SMOC surveillance study -> clinical risk guidelines -> public 🇦🇺 funding for whole body MRI
What next 👇
@UNSW
Liddy shriver award presentation by 🇦🇺 @ballingermandy at #CTOS2023
Incredible work & presentation 🤩 👏
#ISKS -> Genetic predisposition in
#sarcoma -> #SMOC surveillance study -> clinical risk guidelines -> public 🇦🇺 funding for whole body MRI
What next 👇
@UNSW
Really happy to see @ballingermandy receive the 2023 Liddy Shriver Early Research Award for her pioneering work over more than 15 years in sarcoma genetics and early detection to protect people with Li Fraumeni Syndrome. @GarvanInstitute@UNSWMedicine@OmicoAustralia
The #ProgramCommittee of @ctosociety#CTOS2023. It’s been such a fun journey putting the programme together w/ an amazing team of individuals! We have 1 more day to go, but definitely not too early to thank @ashleighg, @GladdyLab, #MaureenO’Sullivan as well as Jennifer & Barbara and president #CarolSwallow for making things happen! 😃
High quality data (as always from @DCalleMD) quantifying the benefit of surgery in high volume centre (13 cases per year) - distance from black line to red/blue line shows magnitude of benefit.
#ctos23